Works matching IS 15257304 AND DT 2024 AND VI 25 AND IP 4


Results: 11
    1

    Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 4, p. 389, doi. 10.1016/j.cllc.2024.02.002
    By:
    • Yusuke Okuma;
    • Shogo Nomura;
    • Jun Sakakibara-Konishi;
    • Yoko Tsukita;
    • Shuji Murakami;
    • Yukio Hosomi;
    • Yuichi Tambo;
    • Yoshihito Kogure;
    • Hiroshige Yoshioka;
    • Motohiro Tamiya;
    • Kiichiro Ninomiya;
    • Eiji Iwama
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8

    Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Lung Cancer Registry Database.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 4, p. 336, doi. 10.1016/j.cllc.2024.01.005
    By:
    • Yusuke Okuma;
    • Yasushi Shintani;
    • Ikuo Sekine;
    • Takehito Shukuya;
    • Koichi Takayama;
    • Akira Inoue;
    • Isamu Okamoto;
    • Katsuyuki Kiura;
    • Nobuyuki Yamamoto;
    • Tomoya Kawaguchi;
    • Etsuo Miyaoka;
    • Ichiro Yoshino;
    • Hiroshi Date
    Publication type:
    Article
    9
    10
    11